STOCK TITAN

Apnimed (APMD) president logs internal stock reclassification and new option grant

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Apnimed, Inc. President Dennis Patrick Molnar reported a series of internal equity adjustments and option grants. On 2026-08-03, each share of Class A Common Stock was reclassified into one share of Common Stock under Rule 16b-7 and Rule 16b-3, resulting in paired dispositions and acquisitions of both common shares and multiple stock option awards at exercise prices ranging from $1.00 to $16.00 per share. A separate stock option for 55,596 shares at $16.00 per share was granted on 2026-07-30, vesting in substantially equal monthly installments over 24 months after July 30, 2026.

Positive

  • None.

Negative

  • None.
Insider Molnar Dennis Patrick
Role President
Type Security Shares Price Value
Disposition Stock Option (Right to Buy) F1, F2 330,210 $0.00 $0.00
Grant/Award Stock Option (Right to Buy) F1, F2 330,210 $0.00 $0.00
Disposition Stock Option (Right to Buy) F1, F2 42,240 $0.00 $0.00
Grant/Award Stock Option (Right to Buy) F1, F2 42,240 $0.00 $0.00
Disposition Stock Option (Right to Buy) F1, F2 148,788 $0.00 $0.00
Grant/Award Stock Option (Right to Buy) F1, F2 148,788 $0.00 $0.00
Disposition Stock Option (Right to Buy) F1, F2 37,064 $0.00 $0.00
Grant/Award Stock Option (Right to Buy) F1, F2 37,064 $0.00 $0.00
Disposition Stock Option (Right to Buy) F1, F3 28,539 $0.00 $0.00
Grant/Award Stock Option (Right to Buy) F1, F3 28,539 $0.00 $0.00
Disposition Stock Option (Right to Buy) F1, F4 37,064 $0.00 $0.00
Grant/Award Stock Option (Right to Buy) Stock Option (Right to Buy) F1, F4 37,064 $0.00 $0.00
Disposition Stock Option (Right to Buy) F1, F5 12,231 $0.00 $0.00
Grant/Award Stock Option (Right to Buy) F1, F5 12,231 $0.00 $0.00
Disposition Stock Option (Right to Buy) F1, F6 55,596 $0.00 $0.00
Grant/Award Stock Option (Right to Buy) F1, F6 55,596 $0.00 $0.00
Disposition Class A Common Stock F1 58,014 -- --
Grant/Award Common Stock F1 58,014 -- --
Grant/Award Stock Option (Right to Buy) F6 55,596 $0.00 $0.00
Holdings After Transaction: Stock Option (Right to Buy) — 654,668 shares (Direct); Stock Option (Right to Buy) Stock Option (Right to Buy) — 37,064 shares (Direct); Class A Common Stock — 0 shares (Direct); Common Stock — 58,014 shares (Direct)
Footnotes (6)
  1. F1. Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock.
  2. F2. 100% of the shares subject to such option are fully vested.
  3. F3. 25% of the shares subject to such option vest and become exercisable when the Reporting Person completes twelve months of continuous service after December 22, 2022, and the remainder of the shares vest and become exercisable in substantially equal quarterly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.
  4. F4. 25% of the shares subject to such option vest and become exercisable when the Reporting Person completes twelve months of continuous service after December 21, 2023, and the remainder of the shares vest and become exercisable in substantially equal quarterly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.
  5. F5. 25% of the shares subject to such option vest and become exercisable when the Reporting Person completes twelve months of continuous service after September 17, 2025, and the remainder of the shares vest and become exercisable in substantially equal quarterly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.
  6. F6. The shares subject to such option vest and become exercisable in substantially equal monthly installments for a period of 24 months after July 30, 2026, subject to the Reporting Person's continuous service to the Issuer on each such date.
Option block at $1.00 330,210 shares at $1.0000 per share Stock Option (Right to Buy) expiring 2029-01-24; reclassified from Class A to Common Stock
Additional $1.00 option block 42,240 shares at $1.0000 per share Stock Option (Right to Buy) expiring 2030-01-29; reclassified from Class A to Common Stock
Option block at $1.06 148,788 shares at $1.0600 per share Stock Option (Right to Buy) expiring 2030-03-31; reclassified from Class A to Common Stock
Option block at $2.74 37,064 shares at $2.7400 per share Stock Option (Right to Buy) expiring 2032-06-14; reclassified from Class A to Common Stock
Option block at $4.00 28,539 shares at $4.0000 per share Stock Option (Right to Buy) expiring 2032-12-22; time-based vesting from December 22, 2022
Option block at $4.87 37,064 shares at $4.8700 per share Stock Option (Right to Buy) expiring 2033-12-21; time-based vesting from December 21, 2023
Option block at $8.88 12,231 shares at $8.8800 per share Stock Option (Right to Buy) expiring 2035-09-19; vesting from September 17, 2025
Option grant at $16.00 55,596 shares at $16.0000 per share Stock Option (Right to Buy) expiring 2036-07-29; monthly vesting over 24 months after July 30, 2026
Rule 16b-7 regulatory
"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3"
A U.S. Securities and Exchange Commission safe-harbor rule that shields corporate insiders (officers, directors and large shareholders) from automatic short-swing profit claims when they buy or sell their company’s stock under a pre-approved, written plan that follows specific timing and nondiscretionary rules. For investors, the rule matters because it distinguishes routine, formula-driven insider transactions from opportunistic trades that could trigger automatic profit recoveries—think of it as an approved autopilot for insider trading that reduces legal uncertainty when the plan’s conditions are met.
Rule 16b-3 regulatory
"Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3"
Rule 16b-3 is a Securities and Exchange Commission regulation that exempts certain routine, pre-approved transactions by company insiders from automatic liability for short-term trading profits. It acts like a safe harbor: if an insider follows a formal plan or the board approves specific transactions in advance, profits from buying and selling company stock within six months are not automatically reclaimed. Investors care because the rule clarifies when insider trades are permissible and reduces uncertainty about potential clawbacks.
Class A Common Stock financial
"each share of Class A Common Stock was reclassified into one share"
Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.
Common Stock financial
"reclassified into one share of Common Stock"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
continuous service financial
"subject to the Reporting Person's continuous service to the Issuer"
stock option financial
"The shares subject to such option vest and become exercisable"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transactions did Apnimed (APMD) President Dennis Patrick Molnar report on August 3, 2026?

Dennis Patrick Molnar reported paired dispositions and acquisitions of Class A and Common Stock and related options on 2026-08-03. These reflect a reclassification of Class A Common Stock into Common Stock and corresponding adjustments to multiple stock option grants, not open-market trades.

How many Apnimed (APMD) options at a $1.00 exercise price were affected in Molnar’s filing?

The filing shows paired transactions involving 330,210 stock options at a $1.00 exercise price and 42,240 options at the same price. Each block was first shown as a disposition of Class A stock options and a matching acquisition of Common Stock options under the reclassification.

What is the vesting schedule for Dennis Molnar’s Apnimed (APMD) option granted at $16.00 per share?

An option for 55,596 shares at $16.00 per share vests in substantially equal monthly installments over 24 months after July 30, 2026. Vesting is conditioned on Molnar’s continuous service to Apnimed on each vesting date.

What reclassification of Apnimed (APMD) shares is disclosed in Molnar’s Form 4?

The footnotes state that, under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock. The Form 4 reflects this with matching dispositions of Class A securities and acquisitions of Common Stock securities.

Are any of Dennis Molnar’s Apnimed (APMD) stock options fully vested according to the Form 4?

Yes. A footnote indicates that for certain options, 100% of the shares subject to those options are fully vested. Other option blocks have time-based vesting schedules tied to Molnar’s ongoing continuous service with the company.

Did Dennis Molnar’s Apnimed (APMD) Form 4 report open-market purchases or sales?

No open-market purchases or sales are shown. The transactions are coded primarily as acquisitions (A) and dispositions to the issuer (D) related to an internal share reclassification and option grants, rather than public market trading activity.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Molnar Dennis Patrick

(Last)(First)(Middle)
APNIMED, INC.
39 JOHN F. KENNEDY STREET, 4TH FLOOR

(Street)
CAMBRIDGE MASSACHUSETTS 02138

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Apnimed, Inc. [ APMD ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
President
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/30/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class A Common Stock08/03/2026D(1)58,014D(1)0D
Common Stock08/03/2026A(1)58,014A(1)58,014D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (Right to Buy)$108/03/2026D(1)330,210 (2)01/24/2029Class A Common Stock330,210$00D
Stock Option (Right to Buy)$108/03/2026A(1)330,210 (2)01/24/2029Common Stock330,210$0330,210D
Stock Option (Right to Buy)$108/03/2026D(1)42,240 (2)01/29/2030Class A Common Stock42,240$00D
Stock Option (Right to Buy)$108/03/2026A(1)42,240 (2)01/29/2030Common Stock42,240$042,240D
Stock Option (Right to Buy)$1.0608/03/2026D(1)148,788 (2)03/31/2030Class A Common Stock148,788$00D
Stock Option (Right to Buy)$1.0608/03/2026A(1)148,788 (2)03/31/2030Common Stock148,788$0148,788D
Stock Option (Right to Buy)$2.7408/03/2026D(1)37,064 (2)06/14/2032Class A Common Stock37,064$00D
Stock Option (Right to Buy)$2.7408/03/2026A(1)37,064 (2)06/14/2032Common Stock37,064$037,064D
Stock Option (Right to Buy)$408/03/2026D(1)28,539 (3)12/22/2032Class A Common Stock28,539$00D
Stock Option (Right to Buy)$408/03/2026A(1)28,539 (3)12/22/2032Common Stock28,539$028,539D
Stock Option (Right to Buy)$4.8708/03/2026D(1)37,064 (4)12/21/2033Class A Common Stock37,064$00D
Stock Option (Right to Buy) Stock Option (Right to Buy)$4.8708/03/2026A(1)37,064 (4)12/21/2033Common Stock37,064$037,064D
Stock Option (Right to Buy)$8.8808/03/2026D(1)12,231 (5)09/19/2035Class A Common Stock12,231$00D
Stock Option (Right to Buy)$8.8808/03/2026A(1)12,231 (5)09/19/2035Common Stock12,231$012,231D
Stock Option (Right to Buy)$1607/30/2026A55,596 (6)07/29/2036Class A Common Stock55,596$055,596D
Stock Option (Right to Buy)$1608/03/2026D(1)55,596 (6)07/29/2036Class A Common Stock55,596$00D
Stock Option (Right to Buy)$1608/03/2026A(1)55,596 (6)07/29/2036Common Stock55,596$055,596D
Explanation of Responses:
1. Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of Common Stock.
2. 100% of the shares subject to such option are fully vested.
3. 25% of the shares subject to such option vest and become exercisable when the Reporting Person completes twelve months of continuous service after December 22, 2022, and the remainder of the shares vest and become exercisable in substantially equal quarterly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.
4. 25% of the shares subject to such option vest and become exercisable when the Reporting Person completes twelve months of continuous service after December 21, 2023, and the remainder of the shares vest and become exercisable in substantially equal quarterly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.
5. 25% of the shares subject to such option vest and become exercisable when the Reporting Person completes twelve months of continuous service after September 17, 2025, and the remainder of the shares vest and become exercisable in substantially equal quarterly installments for a period of 36 months thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.
6. The shares subject to such option vest and become exercisable in substantially equal monthly installments for a period of 24 months after July 30, 2026, subject to the Reporting Person's continuous service to the Issuer on each such date.
/s/Kevin R. Lind, Attorney-in-Fact08/03/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)